Exclusive R & D for Injections
The Companys R&D strengths are in developing
intellectual property in the area of non-infringing processes and resolving
complex chemistry challenges. In the process, Aurobindo Pharma is developing
new drug delivery systems, new dosage formulations, applying new technology
for better processes.
The R&D Center, in Delhi NCR provides a
nurturing environment to a multi-disciplinary team of over 700 scientists
striving for excellence.
The Centre meets cGLP requirements, and is focused on the areas of organic
synthesis, analytical research, dosage form development, pharmacology,
bio-equivalence studies and drug delivery systems.
The instrumentation and analytical knowledge base
at the Centre facilitate
Process
development lifecycles of less than three months, even if it involves
complex multi step synthesis with multiple chirality.
Complete
impurity profiling in all products developed.
Development
of analytical methods and specifications from raw materials, to
non-compendia finished products.
In-house
synthesis of reagents for analyzing organolithiums and noble metals.
